Article Versions Notes

Chen S-Y, Wang C-T, Huang T-H, Tsai J-L, Wang H-T, Yen Y-T, Tseng Y-L, Wu C-L, Chang J-M, Shiau A-L. Advancing Lung Cancer Treatment with Combined c-Met Promoter-Driven Oncolytic Adenovirus and Rapamycin. Cells. 2024; 13(18):1597. https://doi.org/10.3390/cells13181597

Chen, Shih-Yao, Chung-Teng Wang, Tang-Hsiu Huang, Jeng-Liang Tsai, Hao-Tien Wang, Yi-Ting Yen, Yau-Lin Tseng, Chao-Liang Wu, Jia-Ming Chang, and Ai-Li Shiau. 2024. "Advancing Lung Cancer Treatment with Combined c-Met Promoter-Driven Oncolytic Adenovirus and Rapamycin" Cells 13, no. 18: 1597. https://doi.org/10.3390/cells13181597

Chen, S.-Y., Wang, C.-T., Huang, T.-H., Tsai, J.-L., Wang, H.-T., Yen, Y.-T., Tseng, Y.-L., Wu, C.-L., Chang, J.-M., & Shiau, A.-L. (2024). Advancing Lung Cancer Treatment with Combined c-Met Promoter-Driven Oncolytic Adenovirus and Rapamycin. Cells, 13(18), 1597. https://doi.org/10.3390/cells13181597